FEBRUARY 2025LIFE SCIENCES REVIEW1LIFESCIENCESREVIEW.COMISSN 2831 - 8331FEBRUARY - 10 - 2025Dr. Raphael Ribeiro-Pinaud, Chairman and CEOAntharis TherapeuticsAntharis TherapeuticsRedefining Cancer Treatment through Precision Immuno-Oncology$15
Page 2 >